Target intelligence / Profile preview

Dual specificity protein phosphatase 23 (DUSP23)

Target
DUSP23
Molecular classification
Enzyme, Protein tyrosine phosphatase, Dual specificity phosphatase, Class I cysteine-based protein tyrosine phosphatase
01

Overview

Dual specificity protein phosphatase 23 (DUSP23) is a small (≈150–amino acid) enzyme that catalyzes the dephosphorylation of both phosphotyrosine and phosphoserine/threonine residues on substrate proteins. DUSP23 localizes predominantly to the cytoplasm and centrosome, where it regulates G1/S cell cycle progression, cell proliferation, and cell–cell adhesion by dephosphorylating β-catenin at Tyr142, thereby strengthening α–/β–catenin interactions and stabilizing E-cadherin–mediated adherens junctions. It is structurally classified as the smallest catalytically active dual specificity phosphatase and plays roles in signaling pathways relevant to tumorigenesis, angiogenesis, and epithelial tissue homeostasis.

Other names
DUSP23DUSP25LDP-3LDP3VHZMOSPVH1-like phosphatase Zlow molecular mass dual specificity phosphatase 3testicular tissue protein Li 59FLJ20442
02

Mechanism of action

Drugs targeting DUSP23 would function as phosphatase modulators, altering dephosphorylation of key signaling proteins such as ERK1, JNK, p38, and β-catenin

03

Biological functions

Dephosphorylation of phosphotyrosine, phosphoserine, and phosphothreonine residuesRegulation of cell cycle progression (G1/S transition)Regulation of cell proliferationRegulation of cell–cell adhesion via dephosphorylation of β-cateninRegulation of E-cadherin–mediated adherens junctionsSignal transduction
04

Disease associations

Cancer (overexpression linked to increased proliferation in breast cancer, implicated in primary cancers via cell cycle regulation)Potential role in tumorigenesis and vascular biology
05

Safety considerations

Potential risk of promoting cancer cell proliferation or disrupting normal cell cycle/adherens junctions if improperly modulated

Beyond the preview

Go deeper on Dual specificity protein phosphatase 23 (DUSP23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dual specificity protein phosphatase 23 (DUSP23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call